These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23225499)

  • 21. The development of probiotic treatment in obesity: a review.
    Mekkes MC; Weenen TC; Brummer RJ; Claassen E
    Benef Microbes; 2014 Mar; 5(1):19-28. PubMed ID: 23886977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.
    Hampe CS; Roth CL
    Endocrine; 2017 Nov; 58(2):207-227. PubMed ID: 29052181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
    Cani PD; Delzenne NM
    Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
    Isolauri E; Salminen S;
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portrait of a canine probiotic Bifidobacterium--from gut to gut.
    O'Mahony D; Murphy KB; MacSharry J; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
    Vet Microbiol; 2009 Oct; 139(1-2):106-12. PubMed ID: 19523775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.
    Tai N; Wong FS; Wen L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):55-65. PubMed ID: 25619480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes Management by Probiotics: Current Knowledge and Future Pespective.
    Homayouni-Rad A; Soroush AR; Khalili L; Norouzi-Panahi L; Kasaie Z; Ejtahed HS
    Int J Vitam Nutr Res; 2016 Jun; 86(3-4):215-227. PubMed ID: 28436760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
    Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
    Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metagenomics and probiotics.
    Gueimonde M; Collado MC
    Clin Microbiol Infect; 2012 Jul; 18 Suppl 4():32-4. PubMed ID: 22647045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics and prebiotics in animal feeding for safe food production.
    Gaggìa F; Mattarelli P; Biavati B
    Int J Food Microbiol; 2010 Jul; 141 Suppl 1():S15-28. PubMed ID: 20382438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
    Musso G; Gambino R; Cassader M
    Annu Rev Med; 2011; 62():361-80. PubMed ID: 21226616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of gut microbiota in the pathogenesis of obesity and diabetes].
    Stachowicz N; Kiersztan A
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():288-303. PubMed ID: 23619228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.
    Zhang HL; Yu LX; Yang W; Tang L; Lin Y; Wu H; Zhai B; Tan YX; Shan L; Liu Q; Chen HY; Dai RY; Qiu BJ; He YQ; Wang C; Zheng LY; Li YQ; Wu FQ; Li Z; Yan HX; Wang HY
    J Hepatol; 2012 Oct; 57(4):803-12. PubMed ID: 22727732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotics as functional food in the treatment of diarrhea.
    Yan F; Polk DB
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):717-21. PubMed ID: 17053425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.
    Bekkering P; Jafri I; van Overveld FJ; Rijkers GT
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1031-41. PubMed ID: 24138599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotic therapy of intestinal inflammation and infections.
    Sartor RB
    Curr Opin Gastroenterol; 2005 Jan; 21(1):44-50. PubMed ID: 15687884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early nutritional environment: focus on health effects of microbiota and probiotics.
    Laitinen K; Collado MC; Isolauri E
    Benef Microbes; 2010 Nov; 1(4):383-90. PubMed ID: 21831777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.